-
Attribution:
-
Lerner S BCG Unresponsive Disease: A Roadmap for Drug
Development and Novel Therapies
https://www.youtube.com/watch?v=sPKenDA-QW8
(2/18)
-
"Seth Lerner, MD, defines what places a bladder cancer
patient into the BCG unresponsive category and treatment
options in these cases. He touches on valrubicin, summarizes
data regarding off-trial options such as gemcitabine,
docetaxel, and the gem/doce combination, and discusses
clinical trials for CG0070, Ad-IFN and atexolizumab."
-
Grand Rounds in Urology Youtube Channel:
https://www.youtube.com/channel/UCJ9wfEDgPFNQ3Lnrg-u0vCg
|
